Patients with end-stage heart failure are increasingly being treated with implantation of a long-term ventricular assist device. As the use of these devices has grown, health care providers have been faced with managing clinically significant gastrointestinal bleeding in this population. Gastrointestinal bleeding is not uncommon and is reported to occur in 13% to 44% of patients treated with ventricular assist devices. Interestingly, because patients with ventricular assist devices are housed on units accustomed to managing the device, cardiac nurses are often asked about the management of gastrointestinal bleeding. This article describes the possible causes of, the array of diagnostic procedures for, and treatments for this complication. It is critical to develop an understanding of this topic so cardiac nurses can partner with other subspecialty groups to manage this population.
CrowSJohnRBoyleA. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg.2009;137:208–215.
3.
HayesHDemboLLarbalestierRO'DriscollG.Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: A single-center experience. Artif Organs.2010;34:703–706.
4.
JohnRKamdarFLiaoKColvin-AdamsMBoyleAJoyceL.Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thor Surg.2008;86:127–135.
5.
MasonNReidBHarmstanGJonesJBudgeD.Characterization of gastrointestinal bleeding in HeartMate II left ventricular assist devices patients. J Heart Lung Transplant.2010;S175.
6.
WangJWGutherieTEwaldGAGeltmanEMMoazamiJN. Gastrointestinal bleeding complications in continuous flow LVAD patients: Is it device specific?J Heart Lung Transplant.2010;29:8.
7.
SternDKazarmJEdwardsP. Increased incidence of gastrointestinal bleeding following implantation of the Heart*-Mate II LVAD. J Card Surg.2010;25:352–356.
8.
UrielNPakSWJordeU. Acquired von Willebrand syndrome after continuous-flow to high prevalence of bleeding during long term support and at the time of transplantation. J Am Coll Cardiol.2010;56:1207–1213.
9.
LetsouGShahNGregoricIMyersTDelgadoRFrazierO.Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvic 2000 axial-flow left ventricular assist device. J Heart Lung Transplant.2005;24(1):105–109.
10.
JohnRBoyleAPaganiFMillerL.Physiologic and pathologic changes in patients with continuous flow ventricular assist devices. J Cardiovasc Trans Res.2009;2:154–158.
11.
JohnRLeeS.The biological basis of thrombosis and bleeding in patients with ventricular assist devices. J Cardiovasc Trans Res.2009;2:63–70.
12.
GeisenUHeilmannCBeyersdorfF. Non-surgical bleeding in patients with ventricular assist device could be explained By acquired von Willebrand disease. Eur J Cardiothorac Surg.2008;33:679–684.
13.
KlovaiteJGustaffonFMortensenSA. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow ventricular assist device (HeartMate II). J Am Coll Cardiol.2009;53:2162–2167.
14.
DeckerGAMillerEDPashaSFHarrisonMELeightonJA. Deep enteroscopy in patients with left ventricular assist devices: Practical and technical considerations. Endoscopy.2010;42(suppl 2):E194.
15.
MannoMBarberaCBertaniH. Single balloon enteroscopy: Technical aspects and clinical application. World J Gastrointest Endosc.2012;2:28–32.
16.
TulchinskyM.Lower gastrointestinal bleeding diagnosed by red blood cell scintigraphy in a patient with a left ventricular assist device. Clin Nucl Med.2008;33:856–858.
17.
BechtelMWellhonerPChariotosEBucskyBMorshuisMSieversHH. Localizing an occult gastrointestinal bleeding by wireless PillCam SB capsule videoendoscopy in a patient with a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg.2010;139(4):e73–74.
18.
DassASmallMPinkasHBradyP.Safety of conventional and wireless capsule endoscopy in patients supported with nonpulsatile axial flow HeartMate II left ventricular assist device. Gastrointest Endosc.2008;68:379–382.
19.
GarattiABruschiGGirelliCVitaliE.Small intestine capsule endoscopy in magnetic suspended axial left ventricular assist device patient. Interact CardioVasc Thorac Surg.2006;5:1–4.
20.
SmithVSunBLindseyDFirstenbergMS. Surgical management of unusual gastrointestinal bleeding in a left ventricular assist device. Interact CardioVasc Thorac Surg.2010;11:612–613.
21.
OrsiPGuatti-ZulianiCOkolicsanyiL.Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Digest Liver Dis.2001;33:330–334.
22.
ScaglioneGPietriniLRussoFFrancoMRSorrentiniI.Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia. Ailment Pharmacol Ther.2007;6:935–942.
23.
MillerL.The development of the von Willebrand syndrome with the use of continuous flow left ventricular assist devices: A cause-and-effect relationship. J Am Coll Cardiol.2010;56:1214–1215.
24.
PereiraNLChenDKushwahaSSParkSJ. Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices. Interact CardioVasc Thorac Surg.2010;11(4):503–505.
